Dowlati A - Search Results

1

Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors.

Brell JM, Krishnamurthi SS, Rath L, Bokar JA, Savvides P, Gibbons J, Cooney MM, Meropol NJ, Ivy P, Dowlati A. Brell JM, et al. Among authors: dowlati a. Cancer Chemother Pharmacol. 2012 Oct;70(4):547-53. doi: 10.1007/s00280-012-1936-5. Epub 2012 Aug 7. Cancer Chemother Pharmacol. 2012. PMID: 22868341 Free PMC article. Clinical Trial.

2

A brief intensive cisplatin-based outpatient chemotherapy regimen with filgrastim and megestrol acetate support for advanced non-small cell lung cancer: results of a phase II trial.

Levitan N, Dowlati A, Craffey M, Tahsildar H, MacKay W, McKenney J, Remick SC. Levitan N, et al. Among authors: dowlati a. Lung Cancer. 1998 Dec;22(3):227-34. doi: 10.1016/s0169-5002(98)00087-7. Lung Cancer. 1998. PMID: 10048475 Clinical Trial.

3

Multi-institutional phase I/II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small-cell lung carcinoma.

Levitan N, Dowlati A, Shina D, Craffey M, Mackay W, DeVore R, Jett J, Remick SC, Chang A, Johnson D. Levitan N, et al. Among authors: dowlati a. J Clin Oncol. 2000 Mar;18(5):1102-9. doi: 10.1200/JCO.2000.18.5.1102. J Clin Oncol. 2000. PMID: 10694563 Clinical Trial.

4

Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancer.

Dowlati A, Levitan N, Gordon NH, Hoppel CL, Gosky DM, Remick SC, Ingalls ST, Berger SJ, Berger NA. Dowlati A, et al. Cancer Chemother Pharmacol. 2001;47(2):141-8. doi: 10.1007/s002800000211. Cancer Chemother Pharmacol. 2001. PMID: 11269740 Clinical Trial.

5

Phase I clinical and pharmacokinetic study of rebeccamycin analog NSC 655649 given daily for five consecutive days.

Dowlati A, Hoppel CL, Ingalls ST, Majka S, Li X, Sedransk N, Spiro T, Gerson SL, Ivy P, Remick SC. Dowlati A, et al. J Clin Oncol. 2001 Apr 15;19(8):2309-18. doi: 10.1200/JCO.2001.19.8.2309. J Clin Oncol. 2001. PMID: 11304785 Clinical Trial.

6

Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluation.

Dowlati A, Haaga J, Remick SC, Spiro TP, Gerson SL, Liu L, Berger SJ, Berger NA, Willson JK. Dowlati A, et al. Clin Cancer Res. 2001 Oct;7(10):2971-6. Clin Cancer Res. 2001. PMID: 11595684

7

A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer.

Dowlati A, Robertson K, Cooney M, Petros WP, Stratford M, Jesberger J, Rafie N, Overmoyer B, Makkar V, Stambler B, Taylor A, Waas J, Lewin JS, McCrae KR, Remick SC. Dowlati A, et al. Cancer Res. 2002 Jun 15;62(12):3408-16. Cancer Res. 2002. PMID: 12067983 Clinical Trial.

8

Cardiovascular safety profile of combretastatin a4 phosphate in a single-dose phase I study in patients with advanced cancer.

Cooney MM, Radivoyevitch T, Dowlati A, Overmoyer B, Levitan N, Robertson K, Levine SL, DeCaro K, Buchter C, Taylor A, Stambler BS, Remick SC. Cooney MM, et al. Among authors: dowlati a. Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):96-100. doi: 10.1158/1078-0432.ccr-0364-3. Clin Cancer Res. 2004. PMID: 14734457 Clinical Trial.

9

A phase IB clinical and pharmacokinetic study of the angiogenesis inhibitor SU5416 and paclitaxel in recurrent or metastatic carcinoma of the head and neck.

Cooney MM, Tserng KY, Makar V, McPeak RJ, Ingalls ST, Dowlati A, Overmoyer B, McCrae K, Ksenich P, Lavertu P, Ivy P, Hoppel CL, Remick S. Cooney MM, et al. Among authors: dowlati a. Cancer Chemother Pharmacol. 2005 Mar;55(3):295-300. doi: 10.1007/s00280-004-0871-5. Epub 2004 Nov 6. Cancer Chemother Pharmacol. 2005. PMID: 15538570 Clinical Trial.

10

Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer.

Dowlati A, Chapman R, Subbiah S, Fu P, Ness A, Cortas T, Patrick L, Reynolds S, Xu N, Levitan N, Ivy P, Remick SC. Dowlati A, et al. Invest New Drugs. 2005 Dec;23(6):563-7. doi: 10.1007/s10637-005-0754-6. Invest New Drugs. 2005. PMID: 16034518 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters